Tag: CHARM trial
Remedy announces upcoming presentation of “groundbreaking” CHARM study data at ISC...
Remedy Pharmaceuticals has announced that three speaker presentations reporting efficacy data from both the Phase 2 GAMES-RP and Phase 3 CHARM studies on its...
Remedy announces Phase 3 CHARM trial data indicating Cirara’s potential in...
Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a...
